Attention:

Certain features of Sigma-Aldrich.com will be down for maintenance the evening of Friday August 18th starting at 8:00 pm CDT until Saturday August 19th at 12:01 pm CDT.   Please note that you still have telephone and email access to our local offices. We apologize for any inconvenience.

Imidazoline Binding Site Ligands

Product #

Image

Description

Biochem/physiol Actions

Add to Cart

SML1703 2-BFI hydrochloride ≥98% (HPLC) 2-BFI is a high-affinity Imidzoline I2 receptor ligand (Ki = 9.8 nM) In an in vivo functional assay, 2-BFI induces hypothermia in rats.
A7127 Agmatine sulfate salt ≥97%, powder Putative endogenous neurotransmitter at imidazoline receptors; displaces clonidine at α2-adrenergic and at imidazoline receptors; blocks NMDA-activated ion channels in hippocampal neurons.
A9899 Antazoline hydrochloride Imidazoline agonist; more potent than efaroxan in inducing insulin release from β cells; H1 histamine receptor antagonist.
B154 BU224 hydrochloride solid I2 Imidazoline receptor antagonist.
B8433 BU99006 >91% (HPLC) Irreversible I2 imidazoline binding site ligand.
C223 Cirazoline hydrochloride solid Selective α1-adrenoceptor agonist; non-selective imidazoline binding site ligand
C7897 Clonidine hydrochloride solid α2-adrenoceptor agonist; I1 imidazoline binding site ligand.
E3263 Efaroxan hydrochloride ≥98% (HPLC) (+)-Isomer is a selective α-adrenoceptor antagonist; (−)-isomer is an imidazoline ligand that induces insulin secretion, mediated by the blockade of ATP-sensitive potassium channels in pancreatic β cells; I1 imidazoline binding site antagonist.
I6138 Idazoxan hydrochloride α2-adrenoceptor antagonist; I2 imidazoline receptor agonist; I1 imidazoline receptor antagonist
SML1019   Lofexidine hydrochloride ≥98% (HPLC) Lofexidine, a derivative of clonidine, is a very potent agonist of α2 adrenoceptors. Lofexidine is used as a treatment for withdrawl from heroin and other opiates, and as a short-activg anti-hypertensive agent.
M5685 Metrazoline solid Potent and selective imidazoline binding site ligand
SML0862   RX871024 ≥98% (HPLC) RX871024 is an imidazoline receptor antagonist that stimulates insulin secretion in β-cells and islets at lower concentrations than other imidazoline ligands. 0.1 μM RX871024 enhances glucose-induced insulin secretion under nonpolarizing conditions and at higher concentrations, it enhances secretion through a KATP channel-independent mechanism.
R134 Rilmenidine hemifumarate salt solid Selective I1 imidazoline receptor agonist.